Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris
Open Access
- 3 August 2017
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 50 (2), 1602419
- https://doi.org/10.1183/13993003.02419-2016
Abstract
The objective of the study was to estimate the prevalence and incidence of interstitial lung diseases (ILDs) in Seine-Saint-Denis, a multi-ethnic county of Greater Paris, France. Patients with ILDs were identified between January and December 2012 by using several sources; all potentially involved medical specialists from public and private hospitals, community-based pulmonologists and general practitioners, and the Social Security system. Diagnoses were validated centrally by an expert multidisciplinary discussion. 1170 ILD cases were reported (crude overall prevalence: 97.9/105 and incidence: 19.4/105/year). In the 848 reviewed cases, the most prevalent diagnoses were sarcoidosis (42.6%), connective tissue diseases associated ILDs (CTDs-ILDs) (16%), idiopathic pulmonary fibrosis (IPF) (11.6%), and occupational ILDs (5.0%), which corresponded to a crude prevalence of 30.2/105 for sarcoidosis, 12.1/105 for CTDs-ILDs and 8.2/105 for IPF. The prevalence of fibrotic idiopathic interstitial pneumonias, merging IPF, nonspecific interstitial pneumonia and cases registered with code J84.1 was 16.34/105. An adjusted multinomial model demonstrated an increased risk of sarcoidosis in North Africans and Afro-Caribbeans and of CTDs-ILDs in Afro-Caribbeans, compared to that in Europeans. This study, with a comprehensive recruitment and stringent diagnostic criteria, emphasises the importance of secondary ILDs, particularly CTDs-ILDs and the relatively low prevalence of IPF, and confirms that sarcoidosis is a rare disease in France. ILD prevalence reaches 97.9/100000, with a fairly low prevalence of IPF and a high contribution of secondary ILDshttp://ow.ly/vLXq30bssKRKeywords
Funding Information
- Chancellerie des Universités de Paris (Leg Poix)
This publication has 32 references indexed in Scilit:
- Epidemiology and survival of idiopathic pulmonary fibrosis from national data in CanadaEuropean Respiratory Journal, 2016
- Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic reviewEuropean Respiratory Journal, 2015
- Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11The Lancet Respiratory Medicine, 2014
- Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literatureEuropean Respiratory Review, 2012
- Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UKThorax, 2006
- Incidence and Prevalence of Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in FinlandThorax, 2002
- REGISTRATION OF INTERSTITIAL LUNG DISEASES BY 20 CENTRES OF RESPIRATORY MEDICINE IN FLANDERSActa Clinica Belgica, 2001
- Idiopathic Pulmonary Fibrosis: Diagnosis and TreatmentAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Adolescent physical activity and inactivity vary by ethnicity: The National Longitudinal Study of Adolescent HealthThe Journal of Pediatrics, 1999